10.08.2012
- AstraZeneca has opted to pay a further $135 million to Bristol-Myers Squibb to get an equal say in decision-making regarding drugs developed by Amylin Pharmaceuticals, the diabetes...
09.08.2012
- Eli Lilly on Thursday raised its net profit forecast for 2012 to reflect income from the early payment of financial obligations from former partner Amylin Pharmaceuticals, which...
12.07.2012
- Annual global spending on prescription drugs will rise 25% by 2016 to $1.2 trillion, as surging growth in emerging markets eclipses weak gains in developed markets like the United...
20.06.2012
- Institutional investors doubt that treatments for Alzheimer's disease being developed by Pfizer and Eli Lilly will achieve the main goals of their ongoing late-stage trials, but...
19.06.2012
- Drugmaker Eli Lilly, which faces revenue pressure from patent expirations to top products, said it was resuming its program to buy back its stock. The Indianapolis-based company...
19.06.2012
- The U.S. Supreme Court ruled on Monday that pharmaceutical companies do not have to pay overtime to their representatives who visit doctors' offices to promote their products, a...
02.06.2012
- AstraZeneca and Bristol-Myers Squibb are among several pharmaceutical giants that have submitted initial bids for Amylin Pharmaceuticals, the diabetes drugmaker that is exploring a...
07.05.2012
- Swiss drugmaker Roche has ended efforts to develop a heart disease drug which some industry analysts had estimated could have achieved $10 billion in annual sales, after poor...
